Citation Impact
Citing Papers
KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD)
2009 Standout
Organ distribution of cisplatin after intraperitoneal administration of cisplatin-loaded microspheres
2002 StandoutNobel
Practice Guidelines for the Management of Community-Acquired Pneumonia in Adults
2000 Standout
Computer simulations of peritoneal fluid transport in CAPD
1991
Intraperitoneal Cisplatin plus Intravenous Cyclophosphamide versus Intravenous Cisplatin plus Intravenous Cyclophosphamide for Stage III Ovarian Cancer
1996 Standout
Absorption Characteristics of Dextrans with Different Molecular Weights from the Liver Surface Membrane in Rats: Implications for Targeting to the Liver
1996
Human peritoneal mesothelial cell prostaglandin synthesis: Induction of cyclooxygenase mRNA by peritoneal macrophage-derived cytokines
1994
A New Equation to Estimate Glomerular Filtration Rate
2009 Standout
Infections in Patients with Diabetes Mellitus
1999 Standout
Actual Causes of Death in the United States, 2000
2004 Standout
Prostaglandin synthase 2
1996 Standout
Kidney Disease as a Risk Factor for Development of Cardiovascular Disease
2003 Standout
Prostacyclin and Blood Coagulation
1981 StandoutNobel
Dialysis Dose and Intradialytic Hypotension: Results from the HEMO Study
2013 Standout
Intraperitoneal antineoplastic agents for tumors principally confined to the peritoneal cavity
1986
Chronic Hemodialysis Using Venipuncture and a Surgically Created Arteriovenous Fistula
1966 Standout
Cyclooxygenases: Structural, Cellular, and Molecular Biology
2000 Standout
Platelets, Thrombosis and Drugs
1975
Aquaporin-1 and endothelial nitric oxide synthase expression in capillary endothelia of human peritoneum
1998 StandoutNobel
Arterial walls are protected against deposition of platelet thrombi by a substance (prostaglandin X) which they make from prostaglandin endoperoxides
1976 StandoutNobel
Prevention of dialysis disequilibrium syndrome by use of high sodium concentration in the dialysate
1973
Hemodialysis: A Successful Therapy for Chronic Uremia
1966
Are agents affecting platelet functions clinically useful?
1976
Serum Creatinine as an Index of Renal Function: New Insights into Old Concepts
1992 Standout
Urea movement across erythrocyte membrane during artificial kidney treatment
1983
Prostaglandins, their intermediates and precursors: Cardiovascular actions and regulatory roles in normal and abnormal circulatory systems
1979 StandoutNobel
Pulmonary complications of diabetes mellitus. Pneumonia.
1995
Dialysis-associated ischemic heart disease: Insights from coronary angiography
1984
National Kidney Foundation Practice Guidelines for Chronic Kidney Disease: Evaluation, Classification, and Stratification
2003 Standout
Hematological Problems in Pediatric Intensive Care
2013 Standout
PULMONARY COMPLICATIONS OF DIABETES MELLITUS
1995
Correction of the Anemia of End-Stage Renal Disease with Recombinant Human Erythropoietin
1987 Standout
Drug Prescribing in Renal Failure: Dosing Guidelines for Adults.
1988
Preventing and Managing Toxicities of High-Dose Methotrexate
2016 Standout
Works of Maher Jf being referenced
Peritoneal transport rates: mechanisms, limitations, and methods for augmentation.
1980
Modulation of peritoneal transport rates by prostaglandins.
1980
Permselectivity of the peritoneum to neutral dextrans.
1984
Further experience with the use of routine intermittent hemodialysis in chronic renal failure.
1963
Acute effects of hemodialysis on removal of intracellular solutes.
1974
Artificial organs in acute poisoning: to treat or not to treat with artificial organs.
1982
Controlled, double-blind trial of antiplatelet aggregating agents in vascular renal allograft rejection.
1971
Pharmacokinetics in patients with renal failure.
1984
Effect of hemodialysis on factors influencing oxygen transport.
1975